FIELD: medicine, pharmacology.
SUBSTANCE: application of composition, containing rotigotine in concentration of 0.5 to 3 mg/l and at least one chloride salt in concentration of 1 to 140 mmol/l, the composition pH being equal 4 to 6.5, to fill iontophoresis device in treatment for Parkinson's disease, the current density during iontophoresis conduction being in range 200 to 500 mcA/cm2, as well as corresponding treatment method, are proposed.
EFFECT: provides higher rotigotine flow through patient's corneal layer (stratum corneum), compared with conventional passive diffusion systems, and holds significantly higher blood rotigotine levels in Parkinson's disease patients.
8 cl, 3 ex, 3 tbl
Title |
Year |
Author |
Number |
IONOPHORETIC DELIVERY OF ROTIGOTINE FOR TREATMENT OF PARKINSON DISEASE |
2008 |
- Vol'Ff Khans-Mikhaehl'
- Bauvstra Jokhanna Alt'E
- Li Gaj Ling
- Njugrokho Akhmad Kharis
|
RU2478383C2 |
PERCUTANEOUS THERAPEUTIC SYSTEM FOR TREATMENT OF PARKINSON'S DISEASE INDUCING HIGH ROTIGOTIN PLASMA LEVEL |
2002 |
- Lauterbakh Tomas
- Shakht Ditrikh Vil'Khel'M
- Vol'F Khans-Mikaehl'
- Mjuller Val'Ter
|
RU2272625C2 |
ORAL QUICKLY DISSOLVING COMPOSITIONS OF DOPAMINE AGONISTS |
1996 |
- Dzhonson Ehdvard Stjuart
- Klark Ehntoni
- Grin Richard Dehvid
|
RU2189226C2 |
PHARMACEUTICAL COMPOSITIONS FOR TREATING PARKINSON'S DISEASE |
2009 |
- Lamensdorf Itshak
- Sela Joram
|
RU2540470C9 |
IMPROVED TRANSCUTANEOUS THERAPY SYSTEM FOR TREATING PARKINSON DISEASE CASES |
2002 |
- Lauterbakh Tomas
- Shakht Ditrikh Vil'Khel'M
- Vol'F Khans-Mikaehl'
- Mjuller Val'Ter
|
RU2273477C2 |
METHOD OF PRODUCING (2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(((4AR,10AR)-7-HYDROXY-1-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO[G]QUINOLIN-6-YL)OXY)TETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID AND INTERMEDIATE COMPOUNDS FOR ITS PRODUCTION |
2020 |
- Dzhukhl, Martin
- Yakobsen, Mikkel,Fog
- Kvaerno, Lisbet
|
RU2817700C2 |
NEW CATECHOLAMINE-BASED PRODRUGS FOR USE IN TREATMENT OF PARKINSON'S DISEASE |
2018 |
- Jensen Klaus Gervig
- Kvaerno Lisbet
- Dzhukhl Martin
- Jorgensen Morten
|
RU2806075C2 |
PREVENTIVE AND THERAPEUTIC AGENT FOR POSTERIOR EYE DISEASES |
2008 |
- Okamoto Kazuesi
- Sibagaki Keiiti
|
RU2470635C2 |
METHODS OF PARKINSON'S DISEASE TREATMENT |
2004 |
- Rudzhero Far'Ello
- Kattaneo Karlo
- Sal'Vati Patrisija
- Benatti Luka
|
RU2342929C2 |
APPLICATION OF BENZTROPINE TO ABORT PROGRESSION OF AXIAL MYOPIA IN HUMANS |
2017 |
|
RU2793238C2 |